XML 34 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Quarterly Financial Data (Unaudited) (Restated)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data (Unaudited) (Restated)

Note 14 — Quarterly Financial Data (Unaudited) (Restated)

 

In lieu of filing amended Quarterly Report on Form 10-Q for the periods ended March 31, 2019, June 30, 2019, September 30, 2019, March 31, 2020, June 30, 2020, and September 30, 2020, the following tables represent the Company’s restated financial statements (unaudited) for each of the restated periods.

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Assets            
Cash  $296,759   $
-
   $296,759 
Prepaid assets   7,415    
-
    7,415 
Total Current Assets   304,174    
-
    304,174 
              - 
Cash and investments held in Trust Account   116,012,861    
-
    116,012,861 
Total Assets  $116,317,035   $
-
   $116,317,035 
                
Liabilities and Shareholders’ Equity               
Accounts payable and accrued expenses  $4,069   $
-
   $4,069 
Promissory note - related party   300,000    
-
    300,000 
Total Current Liabilities   304,069    
-
    304,069 
                
Warrants liabilities   
-
    585,321    585,321 
Deferred underwriting compensation   4,020,797    
-
    4,020,797 
Total Liabilities   4,324,866    585,321    4,910,187 
                
Commitments and Contingencies   
 
    
 
    
 
 
                
Ordinary shares subject to possible redemption, 10,593,284 and 10,535,331 shares as previously reported and as restated, respectively, at conversion value of $10.10 per share   106,992,168    (585,326)   106,406,842 
                
Shareholders’ Equity:               
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding
   
-
    
-
    
-
 
Ordinary shares, no par value; 300,000,000 shares authorized; 4,096,466 and 4,154,419 shares (excluding 10,593,284 and 10,535,331 shares subject to possible redemption) as previously reported and as restated, respectively   4,123,281    (80,246)   4,043,035 
Retained earnings   876,720    80,251    956,971 
Total Shareholders’ Equity   5,000,001    5    5,000,006 
                
Total Liabilities and Shareholders’ Equity  $116,317,035   $
-
   $116,317,035 

 

   Three Months Ended March 31, 2019 
   As
Previously
       As 
   Reported   Adjustments   Restated 
Operating costs  $153,741   $
-
   $153,741 
Loss from operations   (153,741)   
-
    (153,741)
                
Other income:               
Interest income - bank   143    
-
    143 
Interest income   688,610    
-
    688,610 
Change in fair value of warrant liabilities   
-
    25,857    25,857 
Total other income   688,753    25,857    714,610 
                
Net income   535,012    25,857    560,869 
Less: income attributable to ordinary shares subject to possible redemption   (634,967)   3,443    (631,524)
Adjusted net loss  $(99,955)  $29,300   $(70,655)
                
Basic and diluted weighted average shares outstanding (1)   4,086,448    60,874    4,147,322 
                
Adjusted basic and diluted net loss per ordinary share  $(0.02)  $
-
   $(0.02)

 

  (1) Excludes an aggregate of up to 10,593,284 and 10,535,331 ordinary shares subject to possible redemption as previously reported and as restated, respectively, at March 31, 2019.

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Cash Flows from Operating Activities:            
Net income  $535,012   $25,857   $560,869 
Adjustments to reconcile net income to net cash used in operating activities:             - 
Interest earned on investment held in Trust Account   (688,610)   
-
    (688,610)
Change in fair value of warrant liabilities   
-
    (25,857)   (25,857)
Changes in current assets and current liabilities:               
Prepaid assets   6,347    
-
    6,347 
Accounts payable and accrued expense   (6,020)   
-
    (6,020)
Due to related parties   (2,379)   
-
    (2,379)
Net Cash Used in Operating Activities   (155,650)   
-
    (155,650)
                
Net Decrease in Cash   (155,650)   
-
    (155,650)
Cash – Beginning of the period   452,409    
-
    452,409 
Cash – Ending of period  $296,759   $
-
   $296,759 
                
Supplemental Disclosure of Non-cash Financing Activities:               
Change in value of ordinary shares subject to possible redemption  $535,015   $25,851   $560,866 

 

ALBERTON ACQUISITION CORPORATION
BALANCE SHEET
JUNE 30, 2019
 
   As
Previously
       As 
   Reported   Adjustments   Restated 
Assets            
Cash  $165,890   $
-
   $165,890 
Prepaid assets   1,651    
-
    1,651 
Total Current Assets   167,541    
-
    167,541 
              - 
Cash and investments held in Trust Account   116,706,912    
-
    116,706,912 
Total Assets  $116,874,453   $
-
   $116,874,453 
                
Liabilities and Shareholders’ Equity               
Accounts payable and accrued expenses  $4,272   $
-
   $4,272 
Promissory note - related party   300,000    
-
    300,000 
Total Current Liabilities   304,272    
-
    304,272 
                
Warrants liabilities   
-
    568,672    568,672 
Deferred underwriting compensation   4,020,797    
-
    4,020,797 
Total Liabilities   4,325,069    568,672    4,893,741 
                
Commitments and Contingencies               
                
Ordinary shares subject to possible redemption, 10,585,569 and 10,529,597 shares as previously reported and as restated, respectively, at conversion value of $10.16 per share   107,549,381    (568,677)   106,980,704 
                
Shareholders’ Equity:               
Preference shares no par value, 100,000,000 shares authorized, none issued and outstanding
   
-
    
-
    
-
 
Ordinary shares, no par value; 300,000,000 shares authorized; 4,104,181 and 4,160,153 shares (excluding 10,585,569 and 10,529,597 shares subject to possible redemption) as previously reported and as restated, respectively   3,566,068    (96,895)   3,469,173 
Retained earnings   1,433,935    96,900    1,530,835 
Total Shareholders’ Equity   5,000,003    5    5,000,008 
                
Total Liabilities and Shareholders’ Equity  $116,874,453   $
-
   $116,874,453 

 

   Three Months Ended June 30, 2019   Six Months Ended June 30, 2019 
   As
Previously
       As   As
Previously
       As 
   Reported   Adjustments   Restated   Reported   Adjustments   Restated 
Operating costs  $137,145   $
-
   $137,145   $290,886   $
-
   $290,886 
Loss from operations   (137,145)   
-
    (137,145)   (290,886)   
-
    (290,886)
                               
Other income:                              
Interest income - bank   309    
-
    309    452    
-
    452 
Interest income   694,051    
-
    694,051    1,382,661    
-
    1,382,661 
Change in fair value of warrant liabilities   
-
    16,649    16,649    
-
    42,506    42,506 
Total other income   694,360    16,649    711,009    1,383,113    42,506    1,425,619 
                               
Net income   557,215    16,649    573,864    1,092,227    42,506    1,134,733 
Less: income attributable to ordinary shares subject to possible redemption   (639,499)   3,332    (636,167)   (1,273,984)   6,637    (1,267,347)
Adjusted net loss  $(82,284)  $19,981   $(62,303)  $(181,757)  $49,143   $(132,614)
                               
Basic and diluted weighted average shares outstanding (1)   4,104,181    50,238    4,154,419    4,091,485    59,405    4,150,890 
                               
Adjusted basic and diluted net loss per ordinary share  $(0.02)  $0.01   $(0.01)  $(0.04)  $0.01   $(0.03)

 

  (1) Excludes an aggregate of up to 10,585,569 and 10,529,597 ordinary shares subject to possible redemption as previously reported and as restated, respectively, at June 30, 2019.

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Cash Flows from Operating Activities:            
Net income  $1,092,227   $42,506   $1,134,733 
Adjustments to reconcile net income to net cash used in operating activities:             - 
Interest earned on investment held in Trust Account   (1,382,661)   -    (1,382,661)
Change in fair value of warrant liabilities   -    (42,506)   (42,506)
Changes in current assets and current liabilities:               
Prepaid assets   12,111    
-
    12,111 
Accounts payable and accrued expense   (5,817)   
-
    (5,817)
Due to related parties   (2,379)   
-
    (2,379)
Net Cash Used in Operating Activities   (286,519)   
-
    (286,519)
                
Net Decrease in Cash   (286,519)   
-
    (286,519)
Cash – Beginning of the period   452,409    
-
    452,409 
Cash – Ending of period  $165,890   $
-
   $165,890 
                
Supplemental Disclosure of Non-cash Financing Activities:               
Change in value of ordinary shares subject to possible redemption  $1,092,228   $42,500   $1,134,728 

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Assets            
Cash  $1,237,095   $
-
   $1,237,095 
Total Current Assets   1,237,095    
-
    1,237,095 
              - 
Cash and investments held in Trust Account   117,324,145    
-
    117,324,145 
Total Assets  $118,561,240   $
-
   $118,561,240 
                
Liabilities and Shareholders’ Equity               
Accounts payable and accrued expenses  $5,675   $
-
   $5,675 
Promissory note   1,148,800    
-
    1,148,800 
Promissory note - related party   300,000    
-
    300,000 
Total Current Liabilities   1,454,475    
-
    1,454,475 
                
Warrants liabilities   
-
    548,309    548,309 
Deferred underwriting compensation   4,020,797    
-
    4,020,797 
Total Liabilities   5,475,272    548,309    6,023,581 
                
Commitments and Contingencies               
                
Ordinary shares subject to possible redemption, 10,586,284 and 10,532,581 shares as previously reported and as restated, respectively, at conversion value of $10.21 per share   108,085,960    (548,309)   107,537,651 
                
Shareholders’ Equity:               
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding
   
-
    
-
    
-
 
Ordinary shares, no par value; 300,000,000 shares authorized; 4,103,466 and 4,157,169 shares (excluding 10,586,284 and 10,532,581 shares subject to possible redemption) as previously reported and as restated, respectively   3,029,489    (117,263)   2,912,226 
Retained earnings   1,970,519    117,263    2,087,782 
Total Shareholders’ Equity   5,000,008    
-
    5,000,008 
                
Total Liabilities and Shareholders’ Equity  $118,561,240   $
-
   $118,561,240 

 

   Three Months Ended September 30, 2019   Nine Months Ended September 30, 2019 
   As
Previously
       As   As
Previously
       As 
   Reported   Adjustments   Restated   Reported   Adjustments   Restated 
Operating costs  $80,795   $
-
   $80,795   $371,681   $
-
   $371,681 
Loss from operations   (80,795)   
-
    (80,795)   (371,681)   
-
    (371,681)
                               
Other income:                              
Interest income - bank   146    
-
    146    598    
-
    598 
Interest income   617,233    
-
    617,233    1,999,894    
-
    1,999,894 
Change in fair value of warrant liabilities   
-
    20,363    20,363    
-
    62,869    62,869 
Total other income   617,379    20,363    637,742    2,000,492    62,869    2,063,361 
                               
Net income   536,584    20,363    556,947    1,628,811    62,869    1,691,680 
Less: income attributable to ordinary shares subject to possible redemption   (568,780)   2,901    (565,879)   (1,842,902)   9,399    (1,833,503)
Adjusted net loss  $(32,196)  $23,264   $(8,932)  $(214,091)  $72,268   $(141,823)
                               
Basic and diluted weighted average shares outstanding (1)   4,104,181    55,972    4,160,153    4,095,763    57,758    4,153,521 
                               
Adjusted basic and diluted net loss per ordinary share  $(0.01)  $0.01   $(0.00)  $(0.05)  $0.02   $(0.03)

 

  (1) Excludes an aggregate of up to 10,586,284 and 10,532,581 ordinary shares subject to possible redemption as previously reported and as restated, respectively, at September 30, 2019.

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Cash Flows from Operating Activities:            
Net income  $1,628,811   $62,869   $1,691,680 
Adjustments to reconcile net income to net cash used in operating activities:             - 
Interest earned on investment held in Trust Account   (1,999,894)   
-
    (1,999,894)
Change in fair value of warrant liabilities   -    (62,869)   (62,869)
Changes in current assets and current liabilities:               
Prepaid assets   13,762    
-
    13,762 
Accounts payable and accrued expense   (4,414)   
-
    (4,414)
Due to related parties   (2,379)   
-
    (2,379)
Net Cash Used in Operating Activities   (364,114)   
-
    (364,114)
                
Cash Flows from Financing Activities:               
Proceeds from promissory note   1,148,800    
-
    1,148,800 
Net Cash Provided by Financing Activities   1,148,800    
-
    1,148,800 
                
Net Increase in Cash   784,686    
-
    784,686 
Cash – Beginning of the period   452,409    
-
    452,409 
Cash – Ending of period  $1,237,095   $
-
   $1,237,095 
                
Supplemental Disclosure of Non-cash Financing Activities:               
Change in value of ordinary shares subject to possible redemption  $1,628,807   $62,868   $1,691,675 

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Assets            
Cash  $11,178   $
-
   $11,178 
Prepaid assets   48,625    
-
    48,625 
Total Current Assets   59,803    
-
    59,803 
              - 
Cash and investments held in Trust Account   120,728,495    
-
    120,728,495 
Total Assets  $120,788,298   $
-
   $120,788,298 
                
Liabilities and Shareholders’ Equity               
Accounts payable and accrued expenses  $105,043   $
-
   $105,043 
Promissory note   1,648,800    
-
    1,648,800 
Promissory note - related party   1,080,000    
-
    1,080,000 
Total Current Liabilities   2,833,843    
-
    2,833,843 
                
Warrants liabilities   
-
    516,901    516,901 
Deferred underwriting compensation   4,020,797    
-
    4,020,797 
Total Liabilities   6,854,640    516,901    7,371,541 
                
Commitments and Contingencies               
                
Ordinary shares subject to possible redemption, 10,364,762 and 10,315,581 shares as previously reported and as restated, respectively, at conversion value of $10.51 per share   108,933,649    (516,894)   108,416,755 
                
Shareholders’ Equity:               
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding
   
-
    
-
    
-
 
Ordinary shares, no par value; 300,000,000 shares authorized; 4,324,988 and 4,374,169 shares (excluding 10,364,762 and 10,315,581 shares subject to possible redemption) as previously reported and as restated, respectively   2,181,800    (148,678)   2,033,122 
Retained earnings   2,818,209    148,671    2,966,880 
Total Shareholders’ Equity   5,000,009    (7)   5,000,002 
                
Total Liabilities and Shareholders’ Equity  $120,788,298   $
-
   $120,788,298 

 

   Three Months Ended March 31, 2020 
   As
Previously
       As 
   Reported   Adjustments   Restated 
Operating costs  $149,055   $
-
   $149,055 
Loss from operations   (149,055)   
-
    (149,055)
                
Other income:               
Interest income - bank   827    
-
    827 
Interest income   534,368    
-
    534,368 
Change in fair value of warrant liabilities   
-
    16,418    16,418 
Total other income   535,195    16,418    551,613 
                
Net income   386,140    16,418    402,558 
Less: income attributable to ordinary shares subject to possible redemption   (482,107)   2,298    (479,809)
Adjusted net loss  $(95,967)  $18,716   $(77,251)
                
Basic and diluted weighted average shares outstanding (1)   4,212,191    51,479    4,263,670 
                
Adjusted basic and diluted net loss per ordinary share  $(0.02)  $
-
   $(0.02)

 

(1) Excludes an aggregate of up to 10,364,762 and 10,315,581 ordinary shares subject to possible redemption as previously reported and as restated, respectively, at March 31, 2020.

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Cash Flows from Operating Activities:            
Net income  $386,140   $16,418   $402,558 
Adjustments to reconcile net income to net cash used in operating activities:             - 
Interest earned on investment held in Trust Account   (534,368)   
-
    (534,368)
Change in fair value of warrant liabilities   -    (16,418)   (16,418)
Changes in current assets and current liabilities:               
Prepaid assets   (40,292)   
-
    (40,292)
Accounts payable and accrued expense   91,344    
-
    91,344 
Net Cash Used in Operating Activities   (97,176)   
-
    (97,176)
                
Cash Flows from Investing Activities:               
Purchase of investment held in Trust Account   (1,148,800)   
-
    (1,148,800)
Net Cash Used in Investing Activities   (1,148,800)   
-
    (1,148,800)
                
Cash Flows from Financing Activities:               
Proceeds from promissory note – related party   780,000    
-
    780,000 
Net Cash Provided by Financing Activities   780,000    
-
    780,000 
                
Net Decrease in Cash   (465,976)   
-
    (465,976)
Cash – Beginning of the period   477,154    
-
    477,154 
Cash – Ending of period  $11,178   $
-
   $11,178 
                
Supplemental Disclosure of Non-cash Financing Activities:               
Change in value of ordinary shares subject to possible redemption  $386,139   $16,427   $402,566 

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Assets            
Cash  $9,289   $
-
   $9,289 
Prepaid assets   36,010    
-
    36,010 
Total Current Assets   45,299    
-
    45,299 
              - 
Cash and investments held in Trust Account   14,993,648    
-
    14,993,648 
Total Assets  $15,038,947   $
-
   $15,038,947 
                
Liabilities and Shareholders’ Equity               
Accounts payable and accrued expenses  $156,574   $
-
   $156,574 
Due to related party   100,005    
-
    100,005 
Promissory note   1,748,800    
-
    1,748,800 
Promissory note - related party   1,080,000    
-
    1,080,000 
Total Current Liabilities   3,085,379    
-
    3,085,379 
                
Warrants liabilities   
-
    510,839    510,839 
Deferred underwriting compensation   4,020,797    
-
    4,020,797 
Total Liabilities   7,106,176    510,839    7,617,015 
                
Commitments and Contingencies               
                
Ordinary shares subject to possible redemption, 276,676 and 228,484 shares as previously reported and as restated, respectively, at conversion value of $10.60 per share   2,932,762    (510,833)   2,421,929 
                
Shareholders’ Equity:               
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding
   
-
    
-
    
-
 
Ordinary shares, no par value; 300,000,000 shares authorized; 4,339,562 and 4,387,754 shares (excluding 276,676 and 228,484 shares subject to possible redemption) as previously reported and as restated, respectively   2,303,569    (154,739)   2,148,830 
Retained earnings   2,696,440    154,733    2,851,173 
Total Shareholders’ Equity   5,000,009    (6)   5,000,003 
                
Total Liabilities and Shareholders’ Equity  $15,038,947   $
-
   $15,038,947 

 

   Three Months Ended June 30, 2020   Six Months Ended June 30, 2020 
   As
Previously
       As   As
Previously
       As 
   Reported   Adjustments   Restated   Reported   Adjustments   Restated 
Operating costs  $146,045   $
-
   $146,045   $295,100   $
-
   $295,100 
Loss from operations   (146,045)   
-
    (146,045)   (295,100)   
-
    (295,100)
                               
Other income:                              
Interest income - bank   5    
-
    5    832    
-
    832 
Interest income   24,271    
-
    24,271    558,639    
-
    558,639 
Change in fair value of warrant liabilities   
-
    6,062    6,062    
-
    22,480    22,480 
Total other income   24,276    6,062    30,338    559,471    22,480    581,951 
                               
Net (loss) income   (121,769)   6,062    (115,707)   264,371    22,480    286,851 
Less: income attributable to ordinary shares subject to possible redemption   (4,747)   827    (3,920)   (109,270)   19,050    (90,220)
Adjusted net loss  $(126,516)  $6,889   $(119,627)  $155,101   $41,530   $196,631 
                               
Basic and diluted weighted average shares outstanding (1)   4,324,988    49,181    4,374,169    4,268,590    50,330    4,318,920 
                               
Adjusted basic and diluted net loss per ordinary share  $(0.03)  $0.00   $(0.03)  $0.04   $0.01   $0.05 

 

  (1) Excludes an aggregate of up to 276,676 and 228,484 ordinary shares subject to possible redemption as previously reported and as restated, respectively, at June 30, 2020.

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Cash Flows from Operating Activities:            
Net income  $264,371   $22,480   $286,851 
Adjustments to reconcile net income to net cash used in operating activities:             - 
Interest earned on investment held in Trust Account   (558,639)   
-
    (558,639)
Change in fair value of warrant liabilities   -    (22,480)   (22,480)
Changes in current assets and current liabilities:               
Prepaid assets   (27,677)   
-
    (27,677)
Accounts payable and accrued expense   142,875    
-
    142,875 
Due to related party   100,005    
-
    100,005 
Net Cash Used in Operating Activities   (79,065)   
-
    (79,065)
                
Cash Flows from Investing Activities:               
Purchase of investment held in Trust Account   (1,268,800)   
-
    (1,268,800)
Cash withdrawn from Trust Account to pay redeeming shareholders   105,879,118    
-
    105,879,118 
Net Cash Provided by Investing Activities   104,610,318    
-
    104,610,318 
                
Cash Flows from Financing Activities:               
Proceeds from promissory note – related party   780,000    
-
    780,000 
Proceeds from promissory note   100,000    
-
    100,000 
Redemption of ordinary shares   (105,879,118)   
-
    (105,879,118)
Net Cash Used in Financing Activities   (104,999,118)   
-
    (104,999,118)
                
Net Decrease in Cash   (467,865)   
-
    (467,865)
Cash – Beginning of the period   477,154    
-
    477,154 
Cash – Ending of period  $9,289   $
-
   $9,289 
                
Supplemental Disclosure of Non-cash Financing Activities:               
Change in value of ordinary shares subject to possible redemption  $264,370   $22,488   $286,858 

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Assets            
Cash  $1,595   $
-
   $1,595 
Prepaid assets   19,385    
-
    19,385 
Total Current Assets   20,980    
-
    20,980 
              - 
Cash and investments held in Trust Account   15,174,028    
-
    15,174,028 
Total Assets  $15,195,008   $
-
   $15,195,008 
                
Liabilities and Shareholders’ Equity               
Accounts payable and accrued expenses  $187,604   $
-
   $187,604 
Due to related party   205,000    
-
    205,000 
Promissory notes   1,868,800    
-
    1,868,800 
Promissory note - related party   1,080,000    
-
    1,080,000 
Total Current Liabilities   3,341,404    
-
    3,341,404 
                
Warrants liabilities   
-
    495,105    495,105 
Deferred underwriting compensation   4,020,797    
-
    4,020,797 
Total Liabilities   7,362,201    495,105    7,857,306 
                
Commitments and Contingencies               
                
Ordinary shares subject to possible redemption, 264,008 and 217,866 shares as previously reported and as restated, respectively, at conversion value of $10.73 per share   2,832,801    (495,103)   2,337,698 
                
Shareholders’ Equity:               
Preference shares, no par value, 100,000,000 shares authorized, none issued and outstanding
   
-
    
-
    
-
 
Ordinary shares, no par value; 300,000,000 shares authorized; 4,352,230 and 4,398,372 shares (excluding 264,008 and 217,866 shares subject to possible redemption) as previously reported and as restated, respectively   2,403,530    (170,469)   2,233,061 
Retained earnings   2,596,476    170,467    2,766,943 
Total Shareholders’ Equity   5,000,006    (2)   5,000,004 
                
Total Liabilities and Shareholders’ Equity  $15,195,008   $
-
   $15,195,008 

 

    Three Months Ended September 30, 2020     Nine Months Ended September 30, 2020  
    As
Previously
          As     As
Previously
          As  
    Reported     Adjustments     Restated     Reported     Adjustments     Restated  
Operating costs   $ 100,347     $
-
    $ 100,347     $ 395,447     $
-
    $ 395,447  
Loss from operations     (100,347 )    
-
      (100,347 )     (395,447 )    
-
      (395,447 )
                                                 
Other income:                                                
Interest income - bank     3      
-
      3       835      
-
      835  
Interest income     380      
-
      380       559,019      
-
      559,019  
Change in fair value of warrant liabilities    
-
      15,734       15,734      
-
      38,214       38,214  
Total other income     383       15,734       16,117       559,854       38,214       598,068  
                                                 
Net (loss) income     (99,964 )     15,734       (84,230 )     164,407       38,214       202,621  
Less: income attributable to ordinary shares subject to possible redemption     (71 )     12       (59 )     (104,313 )     18,224       (86,089 )
Adjusted net (loss) income   $ (100,035 )   $ 15,746     $ (84,289 )   $ 60,094     $ 56,438     $ 116,532  
                                                 
Basic and diluted weighted average shares outstanding (1)     4,339,562       48,192       4,387,754       4,292,420       48,465       4,340,885  
                                                 
Adjusted basic and diluted net (loss) income per ordinary share   $ (0.02 )   $ 0.00     $ (0.02 )   $ 0.01     $ 0.02     $ 0.03  

 

  (1) Excludes an aggregate of up to 264,008 and 217,866 ordinary shares subject to possible redemption as previously reported and as restated, respectively, at September 30, 2020.

 

   As
Previously
       As 
   Reported   Adjustments   Restated 
Cash Flows from Operating Activities:            
Net income  $164,407   $38,214   $202,621 
Adjustments to reconcile net income to net cash used in operating activities:             - 
Interest earned on investment held in Trust Account   (559,019)   
-
    (559,019)
Change in fair value of warrant liabilities   
-
    (38,214)   (38,214)
Changes in current assets and current liabilities:               
Prepaid assets   (11,052)   
-
    (11,052)
Accounts payable and accrued expense   173,905    
-
    173,905 
Due to related party   205,000    
-
    205,000 
Net Cash Used in Operating Activities   (26,759)   
-
    (26,759)
                
Cash Flows from Investing Activities:               
Purchase of investment held in Trust Account   (1,448,800)   
-
    (1,448,800)
Cash withdrawn from Trust Account to pay redeeming shareholders   105,879,118    
-
    105,879,118 
Net Cash Provided by Investing Activities   104,430,318    
-
    104,430,318 
                
Cash Flows from Financing Activities:               
Proceeds from promissory note – related party   780,000    
-
    780,000 
Proceeds from promissory note   220,000    
-
    220,000 
Redemption of ordinary shares   (105,879,118)   
-
    (105,879,118)
Net Cash Used in Financing Activities   (104,879,118)   
-
    (104,879,118)
                
Net Decrease in Cash   (475,559)   
-
    (475,559)
Cash – Beginning of the period   477,154    
-
    477,154 
Cash – Ending of period  $1,595   $
-
   $1,595 
                
Supplemental Disclosure of Non-cash Financing Activities:               
Change in value of ordinary shares subject to possible redemption  $164,409   $38,218   $202,627